Biotech · Private company
CeleCor Therapeutics
Track this companyFree. Adds CeleCor Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- zalunfibanPhase 3 · ST-elevation Myocardial Infarction (STEMI)ClinicalTrials.gov · fetched Nov 12, 2026
- RUC-4 CompoundPhase 1 · Coronary DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MIPHASE3 · ACTIVE_NOT_RECRUITING · started Apr 24, 2021ClinicalTrials.gov NCT04825743 · fetched Nov 12, 2026
- A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4PHASE1 · COMPLETED · started Feb 18, 2019ClinicalTrials.gov NCT03844191 · fetched Nov 12, 2026